On to the moon or curtains, page-7

I think BNO would put the stock into a trading halt regardless of the way the results pan out. This would be good practice. Remember, when they get the results they can't read them and interpret them instantaneously. And, it just makes sense to take them in, look though them, prepare the announcement and release a considered statement to the market.

I agree with most of those before me that $0.10, on a "bad" result, is on the "almost impossible" scale. There is a bit more to BNO than that. DDD summed it up pretty well.

Where the SP goes to if the announcement is "all primary endpoints achieved" is tricky to predict. I think $1.00 a share is roughly $500m. That is probably a little on the low side of a fair price for a company that has just posted a positive announcement like that. But, I reckon the true value of BNO is probably far better known to Merck than it is to the local stock market. GLTA